Laboratory Corporation of America Holdings

(LH): Did You Lose Money on Your Laboratory Corp Stock? Contact Johnson Fistel Regarding Investigation

SAN DIEGO- Globe Newswire—January 6, 2022

Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Laboratory Corporation of America Holdings (“Labcorp” or the “Company”) (NYSE: LH).

On January 1, 2022, New York Times released an article regarding the efficacy of Labcorp and other screening labs for certain prenatal tests. The article states that, “A Labcorp MaterniT21 lab report tells patients the test ‘detected’ a problem, even though most studies show positives on that screening are usually wrong.”

If you have information that could assist in this investigation, including past employees and others, or a Labcorp shareholder and are interested in learning more about the investigation, please contact Jim Baker (jimb@johnsonfistel.com) by email or phone at 619-814-4471. If emailing, please include a phone number.

Additionally, you can [click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com

[Click here to join this action]